Movano (MOVE) Health announced that it has opened an investigation to expose apparent manipulation in trading of the company’s common shares, following the recent announcement of a shareholder approved reverse stock split. “We are committed to transparency and protecting the interests of our company and shareholders,” said John Mastrototaro, President and CEO of Movano Health. “It has come to our attention that several small cap stocks have suffered similar manipulation in recent weeks following their respective reverse stock splits, and we are in direct communication with securities regulators, legal counsel and other interested partners, as we pursue this issue to the fullest extent necessary.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on MOVE:
- Movano Inc trading halted, news pending
- Upcoming Stock Splits This Week (October 28 to November 1) – Stay Invested
- Movano Implements Reverse Stock Split to Maintain Nasdaq Listing
- Movano announces 1-for-15 reverse stock split
- Movano plans Response Submission to FDA for EvieMed final review
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.